Plasma sphingolipids and lung cancer: A population-based, nested case-control study

Cancer Epidemiology Biomarkers and Prevention

Volumn 22, Issue 8, 2013, Pages 1374-1382

  Alberg, Anthony J ^a,b   Armeson, Kent ^a,b   Pierce, Jason S ^c   Bielawski, Jacek ^a,c   Bielawska, Alicja ^a,c   Visvanathan, Kala ^d   Hill, Elizabeth G ^a,b   Ogretmen, Besim ^a,c  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^b Departments of Public Health Sciences   (United States)

^c MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^d JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CERAMIDE; CHOLESTEROL; SPHINGANINE; SPHINGOLIPID; SPHINGOSINE 1 PHOSPHATE;

ADULT; ARTICLE; CANCER INCIDENCE; CANCER RISK; CONTROLLED STUDY; DEMOGRAPHY; FEMALE; FOLLOW UP; GEOMETRY; HUMAN; LIQUID CHROMATOGRAPHY; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; POPULATION BASED CASE CONTROL STUDY; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; RACE; SIGNAL TRANSDUCTION; SMOKING; TANDEM MASS SPECTROMETRY;

AGED; CASE-CONTROL STUDIES; CERAMIDES; COHORT STUDIES; FEMALE; HUMANS; LUNG NEOPLASMS; LYSOPHOSPHOLIPIDS; MALE; MARYLAND; MIDDLE AGED; SPHINGOLIPIDS; SPHINGOSINE; TUMOR MARKERS, BIOLOGICAL;

EID: 84882279153     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-12-1424     Document Type: Article

References (21)

1. Furuya H, Shimizu Y, Kawamori T. Sphingolipids in cancer. Cancer Metastasis Rev 2011;30:567-76.
2. Maceyka M, Harikumar KB, Milstien S, Spiegel S. Sphingosine-1-phosphate signaling and its role in disease. Trends Cell Biol 2012;22: 50-60.
3. Ponnusamy S, Meyers-Needham M, Senkal CE, Saddoughi SA, Sentelle D, Selvam SP, et al. Sphingolipids and cancer: Ceramide and sphingosine-1-phosphate in the regulation of cell death and drug resistance. Future Oncol 2010;6:1603-24.
4. Yester JW, Tizazu E, Harikumar KB, Kordula T. Extracellular and intracellular sphingosine-1-phosphate in cancer. Cancer Metastasis Rev 2011;30:577-97.
5. Filosto S, Castillo S, Danielson A, Franzi L, Khan E, Kenyon N, et al. Neutral sphingomyelinase 2: A novel target in cigarette smokeinduced apoptosis and lung injury. AmJ Respir CellMol Biol 2011;44: 350-60.
6. Goldkorn T, Filosto S. Lung injury and cancer: Mechanistic insights into ceramide and EGFR signaling under cigarette smoke.Am J Respir Cell Mol Biol 2010;43:259-68.
7. Uhlig S, Gulbins E. Sphingolipids in the lungs. Am J Respir Crit Care Med 2008;178:1100-14.
8. Chan C, Goldkorn T. Ceramide path in human lung cell death. Am J Respir Cell Mol Biol 2000;22:460-8.
9. Johnson KR, Johnson KY, Crellin HG, Ogretmen B, Boylan AM, Harley RA, et al. Immunohistochemical distribution of sphingosine kinase 1 in normal and tumor lung tissue. J Histochem Cytochem 2005;53: 1159-66.
10. Ponnusamy S, Selvam SP, Mehrotra S, Kawamori T, Snider AJ, Obeid LM, et al. Communication between host organism and cancer cells is transduced by systemic sphingosine kinase 1/sphingosine 1-phosphate signaling to regulate tumour metastasis.EMBO Mol Med 2012;4: 761-75.
11. Bielawski J, Szulc ZM, Hannun YA, Bielawska A. Simultaneous quantitative analysis of bioactive sphingolipids by high-performance liquid chromatography-tandem mass spectrometry. Methods 2006;39: 82-91.
12. Pyne NJ, Tonelli F, Lim KG, Long JS, Edwards J, Pyne S. Sphingosine 1-phosphate signalling in cancer. Biochem Soc Trans 2012;40: 94-100.
13. Pyne NJ, Pyne S. Sphingosine 1-phosphate and cancer. Nat Rev Cancer 2010;10:489-503.
14. Carpinteiro A, Dumitru C, Schenck M, Gulbins E. Ceramide-induced cell death in malignant cells. Cancer Lett 2008;264:1-10.
15. Ogretmen B, Hannun YA. Biologically active sphingolipids in cancer pathogenesis and treatment. Nat Rev Cancer 2004;8:604-16.
16. Kurinna SM, Tsao CC, Nica AF, Jiffar T, Ruvolo PP. Ceramide promotes apoptosis in lung cancer-derived A549 cells by a mechanism involving c-Jun NH2-terminal kinase. Cancer Res 2004;64:7852-6.
17. Debret R, Brassart-Pasco S, Lorin J, Martoriati A, Deshorgue A, Maquart FX, et al. Ceramide inhibition of MMP-2 expression and human cancer bronchial cell invasiveness involve decreased histone acetylation. Biochim Biophys Acta 2008;1783:1718-27.
18. Senkal CE, Ponnusamy S, Manevich Y, Meyers-Needham M, Saddoughi SA, Mukhopadyay A, et al. Alteration of ceramide Synthase 6/C16-ceramide induces activating transcription factor 6-mediated ERstress and apoptosis via perturbation of cellular Ca?2 and ER/Golgi membrane network. J Biol Chem 2011;286:42446-58.
19. Mesicek J, Lee H, Feldman T, Jiang X, Skobeleva A, Berdyshev EV, et al. Ceramide synthases 2, 5, and 6 confer distinct roles in radiationinduced apoptosis in HeLa cells. Cell Signal 2010;22:1300-07.
20. Levy M, Khan E, Careaga M, Goldkorn T. Neutral sphingomyelinase 2 is activated by cigarette smoke to augment ceramide-induced apoptosis in lung cell death. Am J Physiol Lung Cell Mol Physiol 2009;297:L125-33.
21. Cordts F, Pitson S, Tabeling C, Gibbins I, Moffat DF, Jersmann H, et al. Expression profile of the sphingosine kinase signalling system in the lung of patients with chronic obstructive pulmonary disease. Life Sci 2011;89:806-11.